US-China Biomedical Technology, Inc. announced earnings results for the full year ended February 28, 2019. For the full year, the company announced operating loss was USD 522,059 compared to USD 515,522 a year ago. Net loss was USD 710,940 compared to USD 482,164 a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.04 a year ago.